Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Explores Use of iPad App for Early Alzheimer’s Detection
Wall St Cheat Sheet
Sunday, January 12, 2014 - 9:50am
tags:
Pfizer, Alzheimer's disease
Intercept Liver Drug Is A Game Changer For The Biotech Industry
Seeking Alpha
Sunday, January 12, 2014 - 9:47am
tags:
nonalcoholic steatohepatitis, Intercept Pharma, obeticholic acid
Revisiting My Bullish Thesis On Bristol-Myers Squib
Seeking Alpha
Sunday, January 12, 2014 - 9:19am
tags:
Bristol-Myers Squibb
The Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10
Forbes
Saturday, January 11, 2014 - 10:13am
tags:
Neurocrine, Intercept Pharma, Epizyme, Sangamo BioSciences, OncoMed, Zogenix, Macrogenics, Intrexon, Pharmacyclics, Galena Biopharma
LPath Inc. A Small Biotechnology Company With Big Potential
Seeking Alpha
Saturday, January 11, 2014 - 10:10am
tags:
Lpath, iSONEP, Asonep, Lpathomab, Nextomab
Quest Diagnostics Signs Deals
Yahoo/Zacks.com
Saturday, January 11, 2014 - 8:55am
tags:
Quest Diagnostics, diagnostics, Illumina, Ion Torrent, Life Technologies
Proposed Medicare drug change stirs access worries
Yahoo/AP
Saturday, January 11, 2014 - 8:51am
tags:
Medicare, drug access
J&J Innovation settles into a fast-paced global swirl of dealmaking
Fierce Biotech
Saturday, January 11, 2014 - 8:07am
tags:
JNJ Innovation, R&D
Completing a U-turn on RNA, Roche's resurgent pRED strikes deal with Santaris
Fierce Biotech
Saturday, January 11, 2014 - 8:06am
tags:
RNA, Roche, Santaris, pRED, R&D
Compounders start to sign up for FDA oversight
Fierce Pharma
Saturday, January 11, 2014 - 8:04am
tags:
FDA, compounding pharmacies, injectables
New Mandate Will Help Sell Veriteq's FDA-Approved Microchip
Seeking Alpha
Saturday, January 11, 2014 - 8:02am
tags:
FDA, Veriteq, devices, RFID chips
Shares of Chelsea Therapeutics Sink Ahead of FDA Review
Wall St Cheat Sheet
Saturday, January 11, 2014 - 8:01am
tags:
Chelsea Therapeutics, Northera, FDA
Biologic Makers Thwart Generics: Winning Stocks
Seeking Alpha
Saturday, January 11, 2014 - 8:00am
tags:
generics, biologics, Actavis, Mylan, Amgen, Novartis, Pfizer, Teva
Five Prime Therapeutics: A Small Cap With A Big Protein Therapeutic Platform
Seeking Alpha
Saturday, January 11, 2014 - 7:57am
tags:
Five Prime, protein therapeutics
Amgen spinoff Atara cranks its Series B up to $52M
Fierce Biotech
Friday, January 10, 2014 - 6:58pm
tags:
Amgen, Atara, Series B, oncology, kidney disease
KV gets a second shot at forcing the FDA to restrict compounders on Makena
Fierce Pharma
Friday, January 10, 2014 - 6:53pm
tags:
Makena, KV Pharmaceutical, FDA
Arca Biopharma: A Genetically Targeted Drug For Atrial Fibrillation In Heart Failure Patients
Seeking Alpha
Friday, January 10, 2014 - 6:50pm
tags:
ARCA biopharma, atrial fibrillation, Gencaro
Arena Marches Up - Belviq Sales Show Traction
Seeking Alpha
Friday, January 10, 2014 - 6:49pm
tags:
Belviq, Arena Pharmaceuticals
What’s Next for Biotech?
Barron's
Friday, January 10, 2014 - 6:47pm
tags:
Celgene, Alexion, Incyte, Biomarin
Tonix Pharmaceuticals: Expect Pullback, Then Advance After TNX-102 Approval
Seeking Alpha
Friday, January 10, 2014 - 11:10am
tags:
Tonix Pharmaceuticals, TNX-102, fibromyalgia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.